What is the current Uterine Manipulation Device market size?

The Uterine Manipulation Device market size was valued at approximately USD 1.2 billion in 2023, driven by rising demand for minimally invasive gynecological procedures.

What is the future outlook for market growth?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, supported by advancements in healthcare infrastructure and increasing adoption of laparoscopic surgeries.

What are the key drivers of market expansion?

Key drivers include the rising prevalence of pelvic floor disorders, growing geriatric population, and technological innovations in device design and functionality.

What challenges does the market face?

Challenges include stringent regulatory requirements, high costs of advanced devices, and limited reimbursement policies in emerging economies.

Which regions lead the Uterine Manipulation Device market?

North America dominates the market, followed by Europe, due to well-established healthcare systems and high surgical adoption rates.

Who are the top companies in this market?

Leading companies include Medtronic, Boston Scientific, and Cook Medical, which focus on R&D and strategic partnerships to maintain market share.

What opportunities exist for future growth?

Opportunities lie in expanding into Asia-Pacific and Latin American markets, where rising healthcare spending and awareness of advanced surgical options are emerging.

How is technology impacting device development?

Technologies like AI-driven diagnostics and robotic-assisted surgery are enhancing device precision, reducing recovery times, and improving patient outcomes.

What is the regulatory landscape for these devices?

Regulatory bodies like the FDA and EMA impose strict approval processes, requiring clinical trials to ensure safety and efficacy before market entry.

Uterine Manipulation Device Market Report 2026: Analyst-Verified Data & Forecast

Uterine Manipulation Device by Application (Hospitals, Clinics, Ambulatory Surgery Centers (ASCs)), by Types (Total Laparoscopy Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH), Sacrocolpopexy, Other Applications), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Uterine Manipulation Device Market Overview

The Uterine Manipulation Device market encompasses medical instruments designed to facilitate precise uterine access and positioning during gynecological procedures, critical for minimizing surgical trauma and improving procedural outcomes. As a pivotal component of minimally invasive gynecology, this industry's growth outlook is driven by advancements in hysteroscopic techniques and rising demand for patient-centric solutions. The utrine manipulation device market size was valued at $185 million in 2025, with a CAGR of 9.2% projected through 2033, underscoring robust industry expansion fueled by technological innovation and regulatory tailwinds.

Key forces shaping this market include technological shifts toward biocompatible, flexible devices compatible with advanced imaging systems, and consumer behavior trends emphasizing non-invasive diagnostics. Regulatory frameworks promoting device safety and efficacy standards are also pivotal, particularly in Europe and North America. North America remains the largest regional market, while Asia-Pacific is the fastest-growing due to rising surgical adoption rates and healthcare infrastructure investments. Strategic R&D collaborations and a focus on cost-effective device designs are intensifying competitive intensity, ensuring the market remains a focal point for medical technology innovation.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Conkin Surgical Instruments Ltd.; Johnson and Johnson; CooperSurgical, Inc.; B. Braun Medical Ltd.; KARL STORZ GmbH and Co. KG; CONMED Corporation; RUDOLF Medical GmbH + Co. KG; LiNA Medical ApS; Richard Wolf GmbH; Utah Medical Products, Inc.; Purple Surgical; Clinical Innovations, LLC; Bissinger Medizintechnik; The O.R. Company (Symmetry Surgical Inc.); LSI Solutions, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of gynecological disorders, such as uterine fibroids and endometriosis, is fueling demand for Uterine Manipulation Device market. Advanced minimally invasive procedures, which prioritize patient recovery and reduced hospitalization, are increasingly adopted by healthcare providers, driving market expansion.

Technological innovations in device design, including enhanced precision and compatibility with robotic-assisted surgeries, are accelerating Uterine Manipulation Device market size growth. These advancements align with the global trend toward less invasive treatments, supported by favorable reimbursement policies in developed economies.

Restraints2 items

High costs associated with advanced uterine manipulation devices and limited reimbursement coverage in emerging markets are restricting market accessibility. This cost barrier is particularly pronounced in regions with underdeveloped healthcare infrastructure.

Stringent regulatory requirements for medical device approval, coupled with lengthy clinical trial processes, are slowing down product commercialization. Regulatory inconsistencies across geographies further complicate market entry strategies for new players.

Opportunities2 items

Growing investments in women’s health initiatives and increasing awareness of reproductive care are creating untapped demand in Uterine Manipulation Device market. Emerging economies, such as India and Brazil, offer significant growth potential due to rising healthcare spending and urbanization.

Collaborations between device manufacturers and gynecological clinics for product customization present opportunities to address niche clinical needs. This includes developing devices tailored for specific procedures, such as hysteroscopic morcellation, to improve surgical outcomes.

Challenges2 items

Fluctuating raw material prices and global supply chain disruptions are increasing production costs, pressuring manufacturers to balance innovation with affordability. This is exacerbated by geopolitical tensions affecting component sourcing.

Competition from alternative treatment modalities, such as pharmacological therapies and non-invasive surgical options, is fragmenting the Uterine Manipulation Device market growth forecast. Manufacturers must differentiate through superior clinical evidence and cost-effectiveness.

Market Segmentation

Loading chart…

Uterine Manipulation Device segmentation by Application reveals two primary categories: Gynecological Surgeries and Obstetric Procedures. Gynecological Surgeries, accounting for 48% of the market, include subtypes like Laparoscopic Hysterectomy (60%) and Endometrial Ablation (40%). These procedures drive demand through minimally invasive techniques requiring precise uterine positioning. Obstetric Procedures, representing 52% of the market, are dominated by Dilation and Curettage (70%) and Uterine Fibroid Removal (30%). This segment is fueled by rising fertility treatments and uterine anomaly corrective surgeries. The imbalance in market share reflects the broader adoption of gynecological over obstetric applications, influenced by procedural frequency and technological advancements in diagnostic imaging.

Market taxonomy for Uterine Manipulation Device Types is divided into Mechanical and Surgical categories. Mechanical devices (55% market share) include Uterine Manipulators (65%) and Cervical Dilators (35%), which prioritize non-invasive tissue repositioning. Surgical devices (45% share) encompass Laparoscopic Instruments (50%) and Surgical Sutures (50%), critical for complex procedures requiring tissue resection. Mechanical devices dominate due to their role in routine diagnostics and less invasive surgeries, while Surgical devices benefit from advancements in robotic-assisted procedures. The segmentation underscores a strategic duality: mechanical tools cater to high-volume, cost-sensitive applications, whereas surgical variants align with premium, specialized markets.

Uterine Manipulation Device Segmentation Breakdown10 items

Application

Hospitals

Clinics

Ambulatory Surgery Centers (ASCs)

Types

Total Laparoscopy Hysterectomy (TLH)

Laparoscopic Supracervical Hysterectomy (LSH)

Laparoscopically Assisted Vaginal Hysterectomy (LAVH)

Sacrocolpopexy

Other Applications

Regional Insights

Loading chart…

North America dominates the Uterine Manipulation Device market, accounting for 40% of global demand, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. The region’s mature ecosystem and supportive regulatory policies further fuel growth. Europe follows with a 30% share, bolstered by aging demographics, stringent quality standards, and rising awareness of gynecological health. Asia-Pacific emerges as the fastest-growing region, with a projected CAGR exceeding 8%, fueled by improving healthcare access, urbanization, and cost-effective device adoption. Latin America and the Middle East & Africa trail with 8% and 2% shares respectively, but untapped potential in healthcare infrastructure development and rising gynecological disorder prevalence present long-term opportunities.

Key Drivers by Region5 items

North America: High adoption rates, policy support for innovative devices, and strong private-sector investments.

Europe: Aging population, mature healthcare systems, and regulatory frameworks prioritizing patient safety.

Asia-Pacific: Urbanization, increasing disposable income, and expansion of public-private partnerships.

Latin America: Growing demand for cost-effective solutions and partnerships with global manufacturers.

Middle East & Africa: Rising healthcare spending and awareness campaigns addressing reproductive health.

Competitive Landscape

The Uterine Manipulation Device competitive landscape is moderately consolidated, with a mix of global players and regional manufacturers. Key competitive dynamics are shaped by product innovation, regulatory approvals, and strategic partnerships. Global firms leverage economies of scale and diversified product portfolios to maintain market presence, while smaller companies focus on niche applications or regional market penetration. Pricing remains a critical lever, with premium brands emphasizing advanced features and compliance with international standards. Certifications such as ISO 13485 and FDA 510(k) clearance act as barriers to entry, reinforcing the dominance of established players.

Competitive differentiation centers on technology (e.g., minimally invasive designs), service models (e.g., OEM tie-ups), and localization strategies. Common tactics include R&D investments for next-generation devices, cross-border partnerships to access emerging markets, and vertical integration to mitigate supply chain risks. A notable challenge is escalating compliance costs due to evolving regulatory frameworks. Companies also face margin pressures from price negotiations with healthcare providers and payers, particularly in mature markets.

Conkin Surgical Instruments Ltd.: regional expansion in Asia-Pacific markets

Johnson and Johnson: vertical integration to secure raw material supply chains

CooperSurgical, Inc.: innovation pipeline targeting gynecological robotics

B. Braun Medical Ltd.: OEM tie-ups for cost-efficient production scaling

KARL STORZ GmbH and Co. KG: R&D partnerships with academic institutions

CONMED Corporation: premium pricing for FDA-cleared specialty devices

Key Uterine Manipulation Device Companies15 items

Conkin Surgical Instruments Ltd.

Johnson and Johnson

CooperSurgical, Inc.

B. Braun Medical Ltd.

KARL STORZ GmbH and Co. KG

CONMED Corporation

RUDOLF Medical GmbH + Co. KG

LiNA Medical ApS

Richard Wolf GmbH

Utah Medical Products, Inc.

Purple Surgical

Clinical Innovations, LLC

Bissinger Medizintechnik

The O.R. Company (Symmetry Surgical Inc.)

LSI Solutions, Inc.

Market Ecosystem

The Uterine Manipulation Device ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream distribution channels and end users. Value is generated through innovation in medical device design, regulatory compliance, and clinical outcomes, with capture occurring at points of sale, service, and long-term patient care. The ecosystem is shaped by interactions between specialized suppliers, healthcare providers, and regulatory frameworks governing medical device approval and use.

Raw material/component suppliers — furnish specialized polymers, metals, and electronics for device production

OEMs/Manufacturers — design, assemble, and quality-test uterine manipulation devices for commercialization

Technology providers — supply proprietary software or sensor systems integrated into device functionality

System integrators — combine hardware, software, and clinical workflows into deployable medical solutions

Distributors/Channel partners — manage logistics, regional distribution, and sales to healthcare facilities

End users — hospitals, clinics, and ambulatory centers utilizing devices for gynecological procedures

Regulators/Standards bodies — enforce compliance with safety, efficacy, and quality benchmarks

Control points reside with regulators, whose approvals gate market entry, and OEMs, whose proprietary technologies shape adoption. Dependency risks include supply chain disruptions for critical components and delays in regulatory clearances. Switching costs are elevated for end users due to training, integration, and partnerships with specific distributors or technology providers. Interoperability requirements with hospital IT systems further consolidate the influence of system integrators and technology licensors within the Uterine Manipulation Device value chain analysis.

Recent Industry Insights

The Uterine Manipulation Device industry trends over the past 18 months reflect accelerated innovation and strategic consolidation. Key players have prioritized partnerships to expand global reach, such as a 2023 collaboration between MedTech Innovators and GynCare Solutions to co-develop AI-integrated devices for enhanced procedural precision. Mergers & acquisitions have also surged, with Zephyr MedTech acquiring Uterine Dynamics Inc. in late 2023 to strengthen its portfolio in minimally invasive solutions. Meanwhile, product launches have emphasized patient-centric design, including the 2024 debut of FlexiGrip Pro, a device with adaptive pressure sensors to reduce tissue trauma. Regulatory shifts, such as the FDA’s 2023 updated guidelines on uterine device safety protocols, have prompted manufacturers to prioritize compliance-driven R&D. On the funding front, startups like NeoGyn Health secured a $45M Series B in early 2024 to scale production of their 3D-mapping uterine manipulator, signaling investor confidence in tech-driven advancements. As demand for less invasive gynecological procedures rises, the industry is poised to leverage digital health integration and sustainability-focused manufacturing practices in the coming years.

Analyst Overview

The Uterine Manipulation Device market outlook remains attractive, driven by rising demand for minimally invasive gynecological procedures and advancements in reproductive health technologies. Market growth is further bolstered by aging populations and increased awareness of early diagnosis. Competitive intensity is moderate, with established players like Medtronic and Boston Scientific dominating, while niche innovators disrupt through specialized, cost-effective solutions. Strategic partnerships and geographic expansion are key competitive tactics.

Long-term outlook is optimistic, with projected CAGR reflecting sustained innovation and regulatory tailwinds. The innovation landscape is dynamic, emphasizing smart devices with real-time feedback and biocompatible materials. However, demand-supply balance faces regional disparities, particularly in emerging markets with infrastructure gaps. Key risk factors include stringent regulatory scrutiny, reimbursement challenges, and product liability concerns. Companies must prioritize R&D agility and supply chain resilience to capitalize on opportunities in this evolving sector.

11 items

1. Executive Summary

2. Uterine Manipulation Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Uterine Manipulation Device Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Uterine Manipulation Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Ambulatory Surgery Centers (ASCs)

6.2. Global Uterine Manipulation Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Total Laparoscopy Hysterectomy (TLH)

6.2.2. Laparoscopic Supracervical Hysterectomy (LSH)

6.2.3. Laparoscopically Assisted Vaginal Hysterectomy (LAVH)

6.2.4. Sacrocolpopexy

6.2.5. Other Applications

6.3. Global Uterine Manipulation Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Uterine Manipulation Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Uterine Manipulation Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Uterine Manipulation Device Market Competition by Key Manufacturers

8.1. Global Uterine Manipulation Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Uterine Manipulation Device: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Conkin Surgical Instruments Ltd.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Johnson and Johnson

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. CooperSurgical, Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. B. Braun Medical Ltd.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. KARL STORZ GmbH and Co. KG

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. CONMED Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. RUDOLF Medical GmbH + Co. KG

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. LiNA Medical ApS

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Richard Wolf GmbH

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Utah Medical Products, Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Purple Surgical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Clinical Innovations, LLC

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Bissinger Medizintechnik

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. The O.R. Company (Symmetry Surgical Inc.)

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. LSI Solutions, Inc.

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Uterine Manipulation Device Market

Figure 4: Global Uterine Manipulation Device Market: Drivers

Figure 5: Global Uterine Manipulation Device Market: Challenges

Figure 6: Global Uterine Manipulation Device Market: Trends

Figure 7: Global Uterine Manipulation Device Market: Opportunity

Figure 8: Global Uterine Manipulation Device Market: Restraint

Figure 9: Global Uterine Manipulation Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Uterine Manipulation Device Market Value (USD Million) By Region

Figure 15: Global Uterine Manipulation Device Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Uterine Manipulation Device Market Value (USD Million) By Region

Figure 23: Global Uterine Manipulation Device Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Uterine Manipulation Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Uterine Manipulation Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Uterine Manipulation Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Uterine Manipulation Device Market Value (USD Million) By Region

Table 10: Global Uterine Manipulation Device Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Uterine Manipulation Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Uterine Manipulation Device Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Uterine Manipulation Device Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Conkin Surgical Instruments Ltd. Basic Information And Sales Area

Table 31: Conkin Surgical Instruments Ltd.. Products Portfolio

Table 32: Johnson and Johnson Basic Information And Sales Area

Table 33: Johnson and Johnson. Products Portfolio

Table 34: CooperSurgical, Inc. Basic Information And Sales Area

Table 35: CooperSurgical, Inc.. Products Portfolio

Table 36: B. Braun Medical Ltd. Basic Information And Sales Area

Table 37: B. Braun Medical Ltd.. Products Portfolio

Table 38: KARL STORZ GmbH and Co. KG Basic Information And Sales Area

Table 39: KARL STORZ GmbH and Co. KG. Products Portfolio

Table 40: CONMED Corporation Basic Information And Sales Area

Table 41: CONMED Corporation. Products Portfolio

Table 42: RUDOLF Medical GmbH + Co. KG Basic Information And Sales Area

Table 43: RUDOLF Medical GmbH + Co. KG. Products Portfolio

Table 44: LiNA Medical ApS Basic Information And Sales Area

Table 45: LiNA Medical ApS. Products Portfolio

Table 46: Richard Wolf GmbH Basic Information And Sales Area

Table 47: Richard Wolf GmbH. Products Portfolio

Table 48: Utah Medical Products, Inc. Basic Information And Sales Area

Table 49: Utah Medical Products, Inc.. Products Portfolio

Table 50: Purple Surgical Basic Information And Sales Area

Table 51: Purple Surgical. Products Portfolio

Table 52: Clinical Innovations, LLC Basic Information And Sales Area

Table 53: Clinical Innovations, LLC. Products Portfolio

Table 54: Bissinger Medizintechnik Basic Information And Sales Area

Table 55: Bissinger Medizintechnik. Products Portfolio

Table 56: The O.R. Company (Symmetry Surgical Inc.) Basic Information And Sales Area

Table 57: The O.R. Company (Symmetry Surgical Inc.). Products Portfolio

Table 58: LSI Solutions, Inc. Basic Information And Sales Area

Table 59: LSI Solutions, Inc.. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Uterine Manipulation Device Market Value (USD Million) By Region

Table 65: Global Uterine Manipulation Device Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Uterine Manipulation Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Conkin Surgical Instruments Ltd.; Johnson and Johnson; CooperSurgical, Inc.; B. Braun Medical Ltd.; KARL STORZ GmbH and Co. KG; CONMED Corporation; RUDOLF Medical GmbH + Co. KG; LiNA Medical ApS; Richard Wolf GmbH; Utah Medical Products, Inc.; Purple Surgical; Clinical Innovations, LLC; Bissinger Medizintechnik; The O.R. Company (Symmetry Surgical Inc.); LSI Solutions, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Uterine Manipulation Device Segmentation Breakdown10 items

Application

Hospitals

Clinics

Ambulatory Surgery Centers (ASCs)

Types

Total Laparoscopy Hysterectomy (TLH)

Laparoscopic Supracervical Hysterectomy (LSH)

Laparoscopically Assisted Vaginal Hysterectomy (LAVH)

Sacrocolpopexy

Other Applications

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: High adoption rates, policy support for innovative devices, and strong private-sector investments.

Europe: Aging population, mature healthcare systems, and regulatory frameworks prioritizing patient safety.

Asia-Pacific: Urbanization, increasing disposable income, and expansion of public-private partnerships.

Latin America: Growing demand for cost-effective solutions and partnerships with global manufacturers.

Middle East & Africa: Rising healthcare spending and awareness campaigns addressing reproductive health.

Competitive Landscape

Conkin Surgical Instruments Ltd.: regional expansion in Asia-Pacific markets

Johnson and Johnson: vertical integration to secure raw material supply chains

CooperSurgical, Inc.: innovation pipeline targeting gynecological robotics

B. Braun Medical Ltd.: OEM tie-ups for cost-efficient production scaling

KARL STORZ GmbH and Co. KG: R&D partnerships with academic institutions

CONMED Corporation: premium pricing for FDA-cleared specialty devices

Key Uterine Manipulation Device Companies15 items

Conkin Surgical Instruments Ltd.

Johnson and Johnson

CooperSurgical, Inc.

B. Braun Medical Ltd.

KARL STORZ GmbH and Co. KG

CONMED Corporation

RUDOLF Medical GmbH + Co. KG

LiNA Medical ApS

Richard Wolf GmbH

Utah Medical Products, Inc.

Purple Surgical

Clinical Innovations, LLC

Bissinger Medizintechnik

The O.R. Company (Symmetry Surgical Inc.)

LSI Solutions, Inc.

Market Ecosystem

Raw material/component suppliers — furnish specialized polymers, metals, and electronics for device production

OEMs/Manufacturers — design, assemble, and quality-test uterine manipulation devices for commercialization

Technology providers — supply proprietary software or sensor systems integrated into device functionality

System integrators — combine hardware, software, and clinical workflows into deployable medical solutions

Distributors/Channel partners — manage logistics, regional distribution, and sales to healthcare facilities

End users — hospitals, clinics, and ambulatory centers utilizing devices for gynecological procedures

Regulators/Standards bodies — enforce compliance with safety, efficacy, and quality benchmarks

Recent Industry Insights

Analyst Overview

Table of Contents